ArticleJournal of pharmacokinetics and pharmacodynamics2024

QSP modeling of a transiently inactivating antibody-drug conjugate highlights benefit of short antibody half life.

Eshita Khera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.